drug
lusutrombopag
Marketedupdated 5mo agoby $SGIOF SHIONOGI & CO LTD
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 29, 2028
~1.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Sep 29, 2031formulationUS 94274025.0y
- Jan 21, 2030compositionUS 85306683.3y
- Jul 29, 2028compositionUS 88897221.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that